Voyager Therapeutics Inc.
(VYGR) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | 2.74 | -5.04 | -1.55 | 7.23 | -12.26 | -3.41 | -6.29 | -8.02 | -3.09 | -16.01 | -1.07 |
PS Ratio | 1.45 | 5.72 | 2.73 | 1.55 | 4.80 | 39.56 | 43.90 | 22.67 | 5.30 | n/a | n/a |
PB Ratio | 1.54 | 3.96 | 1.07 | 1.72 | 5.03 | 6.49 | 3.32 | 2.37 | 0.54 | 227.29 | -2.14 |
P/FCF Ratio | 4.86 | -15.6 | -1.85 | -2.44 | 12.23 | -14.93 | -6.81 | -6.78 | 2.28 | -17.52 | -1.51 |
P/OCF Ratio | 4.66 | -18.7 | -1.91 | -2.75 | 10.29 | -18.97 | -7.25 | -7.59 | 2.22 | -21.91 | -1.51 |
OCF/S Ratio | 0.31 | -0.31 | -1.43 | -0.57 | 0.47 | -2.09 | -6.05 | -2.99 | 2.38 | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.49 | -0.76 |
Quick Ratio | 4.96 | 1.70 | 2.65 | 7.13 | 3.98 | 4.97 | 10.69 | 12.84 | 9.41 | 3.38 | 0.03 |
Current Ratio | 4.96 | 1.72 | 2.68 | 7.39 | 4.01 | 5.13 | 10.81 | 12.95 | 8.19 | 3.38 | 0.03 |
Asset Turnover | 0.71 | 0.26 | 0.19 | 0.65 | 0.29 | 0.04 | 0.05 | 0.08 | 0.08 | n/a | n/a |
Interest Coverage | n/a | -28.37 | n/a | n/a | n/a | n/a | n/a | -42.31 | -61.01 | n/a | n/a |
Return on Equity (ROE) | 0.56 | -0.79 | -0.69 | 0.24 | -0.41 | -1.9 | -0.53 | -0.3 | -0.18 | -14.2 | 2.00 |
Return on Assets (ROA) | 0.38 | -0.29 | -0.34 | 0.14 | -0.12 | -0.5 | -0.38 | -0.21 | -0.13 | -1.42 | -51.45 |
Return on Capital (ROIC) | 0.43 | -0.59 | -0.52 | 0.12 | -0.19 | -0.63 | -0.43 | -0.23 | -0.1 | -1.59 | 1.97 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 98.22% | 84.87% | -97.21% | 36.45% | -14.7% | -751.88% | -514.31% | -197.11% | -59.68% | n/a | n/a |
Net Profit Margin | 52.93% | -113.45% | -176.49% | 21.47% | -39.11% | -1.16K% | -697.56% | -282.65% | -171.18% | n/a | n/a |
Pretax Profit Margin | 53.49% | -113.41% | -190.29% | 21.47% | -41.76% | -1.16K% | -697.56% | -282.29% | -171.18% | n/a | n/a |
Operating Profit Margin | 48.80% | -124.27% | -196.76% | 16.00% | -49.51% | -1.20K% | -709.06% | -290.43% | -116.85% | n/a | n/a |
FCF Margin | 29.86% | -36.67% | -147.36% | -63.59% | 39.23% | -265.02% | -644.65% | -334.11% | 232.31% | n/a | n/a |
EBITDA Margin | 50.58% | -109.14% | -182.96% | 18.23% | -46.86% | -1.17K% | -693.32% | -286.13% | -113.38% | n/a | n/a |